863237-58-5

Upstream product

• 863237-56-3 2,4-bis-benzyloxy-6-hydroxy-benzaldehyde 
• 863237-41-6 4,6-dibenzyloxy-2-methoxymethyloxybenzaldehyde 
• 28924-21-2 3,5-dibenzyloxyacetophenone 
• 487-70-7 2,4,6-trihydroxybenzaldehyde 
• 100-39-0 benzyl bromide 
• 863237-49-4 3',4,5',6-tetrabenzyloxy-2-methoxymethyloxy-E-retro-chalcone 

Downstream Products

• 863237-50-7 1-(3',5'-dibenzyloxyphenyl)-3-(2''-methoxymethyloxy-4'',6''-dibenzyloxyphenyl)propan-1-ol 
• 863237-51-8 (E)-(5-(3-(2,4-bis(benzyloxy)-6-(methoxymethoxy)-phenyl)prop-1-enyl)-1,3-phenylene)bis(oxy)bis(methylene)-dibenzene 
• 863237-60-9 1,5-Bis-benzyloxy-2-[3-(3,5-bis-benzyloxy-phenyl)-3-bromo-propyl]-3-methoxymethoxy-benzene 
• 863237-53-0 (1R,2R)-1-(3',5'-dibenzyloxyphenyl)-3-(2''-hydroxy-4'',6''-dibenzyloxyphenyl)propane-1,2-diol 
• 863237-52-9 (1R,2R)-1-(3',5'-dibenzyloxyphenyl)-3-(2''-methoxymethyloxy-4'',6''-dibenzyloxyphenyl)propane-1,2-diol 

Relevant academic research and scientific papers

Asymmetric total synthesis of B-ring modified (-)-epicatechin gallate analogues and their modulation of β-lactam resistance in Staphylococcus aureus

Two enantiomerically pure B-ring modified analogues of (-)-epicatechin gallate were synthesised and their modulation of β-lactam resistance using three strains of methicillin resistant Staphylococcus aureus (BB 568, EMRSA-15 and EMRSA-16) evaluated. Sub-i